Breaking Through Cancer?
"Cure" isn't a word that's used very often in the cancer field. Still, a 20-year-in-the-making breakthrough could make that word more common among oncologists .
Overcoming Transplant Rejection
Blood cancers - leukemia, lymphoma and myeloma - interfere with the body's ability to make healthy blood cells. Scientists may have discovered a new way to treat these diseases in ways that offer new hope.
When One Drug Doesn't Work Another One Does
The medication Gleevec ( imatinib ) remains the standard of care for people newly diagnosed with chronic myeloid leukemia ( CML ). But not all patients respond well to this medicine, and now they have an alternative.
The Risks of Rural Life
It seems so idyllic - the farm life does. Yet new research finds that children who grew up on a livestock farm are at greater risk for developing certain types of cancer.
CML Hope After all Else has Failed
Leukemia begins in the bone marrow. Medications can treat most forms of this cancer, but drugs don't work for everyone. Scientists are trying to find new answers – and hope.
New Therapy for Leukemia in the Works
Chronic myeloid leukemia ( CML ) results when the growth of white blood cells goes berserk and too many are produced in the bone marrow. A new method to treat this disease is being studied.
One of the "Easy Cancers"
A patient remembers the day he was diagnosed. Writing on a patient support group forum, he recalls, "I had one of the first oncologists I saw tell me 'you got the cancer I can treat. One pill a day and you carry on. Who's luckier than you?'"
New Drug Therapy Shows Promise in Treating Leukemia
Acute lymphoblastic leukemia is the most common type of childhood cancer. A new drug therapy holds promise in treating this particularly aggressive disease.
Preventing Children's Cancers From Returning
Acute lymphoblastic leukemia (ALL) used to be one of the deadliest cancers for children and young adults. Now it's one of the most curable, and cures rates are climbing.
Understanding of Alzheimer's Expanding
If we only knew exactly what caused Alzheimer's disease, it might be easier to treat. Scientists are making headway in both arenas.